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Cancer risk in relation to body fat 
distribution, evaluated by DXA-
scans, in postmenopausal women 
– the prospective epidemiological 
Risk Factor (peRF) study
Line Mærsk staunstrup1,2, Henning Bay Nielsen4, Bente Klarlund pedersen3, Morten Karsdal4, 
Joseph patrick Michele Blair1,2, Jesper Frank Christensen3 & Cecilie Liv Bager1
studies with direct measures of body fat distribution are required to explore the association between 
central and general obesity to cancer risk in postmenopausal women. this study investigates 
the association between central obesity and general obesity to overall/site-specific cancer risk in 
postmenopausal women. The analysis included 4,679 Danish postmenopausal women. Body fat 
distribution was evaluated by whole-body dual-energy X-ray absorptiometry scanners. Cancer 
diagnoses were extracted from the Danish Cancer Registry and multivariable Cox regression models 
explored the association between cancer risk and central obesity after adjusting for BMI. our results 
showed that high central obese women had a 50% increased risk of overall cancer relative to low 
central obese women (Q1vs.Q4: [HR:1.50, CI:1.20–1.88]). For site-specific cancers, central obesity was 
significantly associated with Respiratory (Q1vs.Q4: [HR:2.01, CI:1.17–3.47]), Gastrointestinal (Q1vs.
Q4: [HR:1.55, CI:0.99–2.41]) and Female genital organs (Q1vs.Q4: [HR:1.95, CI:1.00–3.78]) cancer 
diagnoses. Sub-analyses stratified by smoking-habits found a significant association between central 
obesity and a cancer diagnosis for current (Q1vs.Q4: [HR:1.93, CI:1.25–2.99]) and former smokers 
(Q1vs.Q4: [HR:1.90, CI:1.23–2.94]). These analyses suggest that central obesity is associated with some 
cancers in postmenopausal women independent of BMI.
Obesity is an increasing problem in developed countries comprising a major global health challenge1. A national 
health profile made by the Danish Health Authority showed that 51.5% of Danish women in the age range 
of 65–74 years were overweight or obese in 20172. The same trend of increasing obesity among the elderly is 
observed in the rest of the western world3.
Several epidemiological studies have evaluated the link between obesity and cancer risk4–6. There is strong 
evidence that obesity, measured by BMI, is a risk factor for a variety of different cancers, including oesophagus, 
pancreas, liver, colorectum, breast (postmenopausal) and ovary cancer6. It is estimated that almost 10% of cancer 
incidences in 2012 were due to overweight or obesity7. However, the current body of evidence relies almost exclu-
sively on indirect anthropometric measures of obesity, e.g. body mass index (BMI), waist circumference (WC) 
and/or waist-to-hip ratio (WHR)8, which are associated with major limitations. In women, menopause initiates a 
shift of body fat towards a higher level of abdominal/visceral adiposity9, which is not captured by BMI. Moreover, 
anthropometric measures fail to differentiate between lean and fat mass10. Thus, studies with direct measures 
of body fat distribution are required to explore the association between body fat distribution and cancer risk in 
postmenopausal women. To this end, dual-energy X-ray absorptiometry (DXA) scanning is the gold standard 
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for direct determination of whole-body and regional distribution of lean and fat mass, but only a few large-scale 
epidemiological studies have applied this method11.
The present study explored the association between body fat distribution in postmenopausal women and 
cancer risk using data from the Prospective Epidemiological Risk Factor (PERF) study12.
Here, DXA scans were available at baseline and data for cancer diagnoses along with death records for 5,855 
Danish postmenopausal women were retrieved over a 12-year follow-up period. Accordingly, we examined the 
association between obesity and overall cancer risk in the postmenopausal women included in the PERF cohort. 
Obesity was measured both by BMI and trunk-to-peripheral fat ratio, to reflect overall and central obesity respec-
tively. The principal objective was to explore the potential discrepancy between whole-body and regional obesity 
derived from DXA-scans adjusted for known risk factors for cancer and mediators of obesity. We further explored 
the association between obesity and site-specific cancer risk, and finally stratified our analyses by smoking habits 
as a potential moderating factor13.
Methods
study population. PERF is an observational, prospective cohort consisting of 5,855 Danish postmenopausal 
women12. Women who previously participated in clinical prevention trials or had been screened for inclusion 
in randomized clinical prevention trials at the Center for Clinical and Basic Research (CCBR) were invited to 
participate in PERF. The characteristics obtained in the PERF cohort including lifespan and disease history are 
comparable with known distributions from elderly Danish women according to statistics Denmark14. The study 
was designed to obtain knowledge about the determinants of age-related diseases in elderly women and the par-
ticipants are considered representative of postmenopausal Danish women.
Data collection and variable definition. The PERF baseline population was examined between 1999 and 
2001 at CCBR located in either Ballerup or Aalborg (Denmark)12. The examination included a comprehensive 
medical workup along with an interview with a doctor or a nurse covering questions related to lifestyle, demo-
graphics, family disease history, reproduction, smoking history, alcohol consumption and level of education. All 
participants had their weight and height measured which allowed for calculation of BMI (kg/m2).
Participants of the study were matched to the Danish Cancer Registry, the National Danish Causes of Death 
Registry, the Danish National Patient Register15 and the Danish adult diabetes registry16 through a personal sub-
ject identification number (CPR-number). Cancer categories were classified according to WHOs international 
Classification of Diseases 10 (ICD10) [Non-solid and non-malignant tumours (D04, D10–48, C44, C81–96, N87); 
Breast cancers (C50, D05); Female genital organs (FGO) cancers (C51–58, D06); Respiratory cancers (C30–39, 
D02); Gastrointestinal (GI) cancers (C15–26, D00–01); and Other cancers (C00–14, C40–41, C43–49, C64–80, 
D03, D07, D09)]. Co-morbidities at baseline were extracted from the Danish National Patient Register and the 
Danish adult diabetes registry.
Body fat measurements. Regional adiposity (legs, arms, trunk and head fat mass (g)) measures were per-
formed with DXA scanners (HOLOGIC QDR-4500, HOLOGIC QDR-2000, Lunar Prodigy). Central obesity was 
defined as the trunk-to-peripheral fat ratio17 and was calculated by division of fat mass in the trunk area with fat 
mass in arms and legs. DXA-scans were normalized into z-scores for analysis with the largest population as the 
reference (HOLOGIC QDR-4500). Before doing so it was insured that the three groups had the same age, weight 
and height distribution. Central obesity was normally distributed and DXA-scan measures of this cohort were 
consistent with reference values provided by T. Kelly et al.18. For analysis and comparison, the central obesity and 
BMI variables were divided into quartiles.
Inclusion criteria. Women with a diagnosis of solid cancer after baseline and women not present in the 
Danish Cancer Registry (non-cases) were included in the analysis. Women with only non-solid cancer or 
non-malignant tumours specified as benign tumours, non-melanoma skin cancer, hematologic cancer, desmopla-
sia and neoplasms of uncertain behaviour were excluded from the analysis. Lastly, women with a cancer diagnosis 
within the first 6 months after baseline were removed to reduce the risk of reverse causality (Fig. 1). In the case of 
a woman having more than one solid cancer diagnosis at least 6 months after baseline, only the first incident of 
cancer was included in the analysis.
statistical analysis. All continuous variables were normally distributed. Continuous and categorical base-
line characteristics of women with and without a cancer diagnosis were compared using a t-test and a chi-squared 
test, respectively (Table 1). A Cox regression model was applied in both a univariable and multivariable regression 
fashion to estimate overall cancer risk (Table 2). In the multivariable analysis, the covariates selected for the final 
model was based on a directed acyclic graph (DAG) (Figure S1). The following covariates were included: BMI 
[Quartiles (<23.19; 23.19 ≤ 25.72; 25.72 ≤ 28.68; >28.68)]; Recreational walking (≥5 times/week, min. 10 min-
utes); Exercise habits (≥1 time/week); Level of education (school (9 years)/high school (12 years)/university (17 
years)); Smoking habits (never/former/current); Childbirth (≥1 child); Alcohol consumption (≥7 units/week) 
and Central obesity [Quartiles (<0.71; 0.71 ≤ 0.86; 0.86 ≤ 1.02; >1.02)].
The time-scale of the model was age. Participants entered the analysis with their baseline age and exited with 
their age when they first got a cancer diagnosis at least 6 months after baseline. Non-cases exited the analysis with 
their censoring-age being the age at the end of the study (December 2012), the age when leaving Denmark or 
the age at death, whichever came first. Age was used as time-scale in the Cox analyses to ensure that the estima-
tion was based on comparisons of individuals of the same age to prevent confounding by age19.
Multivariable Cox regression models stratified by smoking habits were done by classifying the participants 
into three groups: never, former and current smokers. To test for trends in the categorical obesity variables, study 
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participants were assigned with the median value within their quartile and the resulting variable was fitted as a 
continuous variable in the regression models.
Variance inflation factor (VIF) values were estimated for each regression model. None of the VIF values were 
larger than 3 indicating no existence of collinearity. All statistical analyses were performed using R (V.3.3.2) and 
the survival package (V.2.40.1). Level of statistical significance was 0.05.
ethics statement. The PERF study protocol was approved by the Copenhagen County Scientific Ethics 
Committee (jr: KA 99070 gm). All participants in the present analysis provided written informed consent. All 
methods were carried out in accordance with the approved guidelines and regulations.
Results
Cohort characteristics. Of the 4,679 women who were DXA-scanned in the PERF I study, 809 were diag-
nosed with cancer at least 6 months after baseline and 3870 women had no history of cancer (non-cases) (Fig. 1).
Table 1 summarizes the baseline characteristics of the cohort. On average, the women were 71 ± 6.5 years 
old (range: 49–89 years) with a BMI of 26.2 ± 4.2. Age at baseline, smoking habits and central obesity were sig-
nificantly different between women with a cancer diagnosis and non-cases. None of the other variables differed 
significantly between the two groups. A correlation analysis showed that BMI and DXA-derived central obesity 
measurements were weakly correlated (R ≤ 0.35).
Figure 1. Flow chart showing the organization and categorization of postmenopausal women included in the 
study.
4Scientific RepoRts |          (2019) 9:5379  | https://doi.org/10.1038/s41598-019-41550-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
Previous history of disease for the women in the total cohort was distributed in the following way: 23% had 
a history of diseases of the circulatory system, 11% had a history of diseases of the respiratory system, 21% had a 
history of diseases of the digestive system and 25% had a history of diseases of the musculoskeletal system.
obesity and overall cancer risk. To determine if body fat distribution was associated with cancer risk, 
both univariable and multivariable Cox regression analyses were conducted (Table 2).
In the univariable Cox regression, the DXA-derived measure of central obesity showed strong positive signifi-
cant associations with overall cancer risk, whereas BMI was not associated significantly with cancer risk (Table 2). 
In the multivariable Cox regression analysis the fourth quartile of central obesity was independently associated 
with increased overall cancer risk compared with the first quartile after adjustment for covariates age at baseline, 
BMI, smoking habits, education, recreational walking, exercise habits, childbirth and alcohol consumption (HR: 
1.50, CI: 1.20-1.88) (Table 2). A test for trend over the quartiles of central obesity was also significant (p for trend: 
p < 0.001). BMI was not significantly associated with overall cancer risk, and a test for trend over the quartiles was 
likewise non-significant (p for trend: p = 0.56).
Obesity and site-specific cancer risk. To determine whether the results were applicable to all types of 
cancer, five multivariable Cox regression analyses with different site-specific cancers were performed. The cancer 
diagnoses were distributed between the five site-specific categories in the following way: GI: n = 223; respiratory: 
n = 122; FGO: n = 108; breast: n = 185; other: n = 171.
For respiratory cancers, the results showed that the fourth quartile of central obesity was significantly associ-
ated with increased cancer risk when compared to the first quartile (HR: 2.01, CI: 1.17-3.47). For BMI both the 
third and fourth quartiles of BMI were significantly negatively associated with cancer risk compared to the first 
Characteristics
Total cohort 
(n = 4,679)
Women with a cancer 
diagnosis (n = 809)
Non-
cases*(n = 3,870) P-val **
Age at baseline (years)
   Mean ± SD (n) 70.7 ± 6.5 (4679) 71.5 ± 6.1 (809) 70.5 ± 6.6 (3870) <0.0001
BMI (kg/m2)
   Mean ± SD (n) 26.2 ± 4.2 (4501) 26.3 ± 4.3 (773) 26.1 ± 4.2 (3728) 0.32
   Q1, n/total (%) 1125/4501 (25.0) 188/773 (24.3) 938/3728 (25.2)
0.79
   Q2, n/total (%) 1125/4501 (25.0) 192/773 (24.8) 933/3728 (25.0)
   Q3, n/total (%) 1125/4501 (25.0) 189/773 (24.5) 936/3728 (25.1)
   Q4, n/total (%) 1126/4501 (25.0) 204/773 (26.4) 921/3728 (24.7)
Recreational walking (min. 10 minutes)
   ≥5 times/week, yes/no 3356/1315 559/249 2797/1066
0.07
(total n) (%yes) (72) (4671) (69) (808) (72) (3863)
Exercise habits
   ≥1 time/week, yes/no 3208/1463 539/269 2669/1194
0.20
   (%yes) (total n) (69)(4671) (67)(808) (69)(3863)
Education
   School (9 years) n/total (%) 3357/4671 (71.9) 591/809 (73.1) 2766/3862 (71.6)
0.40   high school (12 years) n/total (%) 991/4671 (21.2) 158/809 (19.5) 833/3862 (21.6)
   University (17 years) n/total (%) 323/4671 (6.9) 60/809 (7.4) 263/3862 (6.8)
Smoking
   Never, n/total (%) 2221/4671 (47.) 204/809 (25.2) 1888/3862 (48.9)
0.003   Former, n/total (%) 1395/4671 (29.9) 272/809 (33.6) 1123/3862 (29.1)
   Current, n/total (%) 1055/4671 (22.6) 333/809 (41.2) 851/3862 (22.0)
Childbirth
   ≥1 child, yes/no 4168/500 706/102 3462/398
0.06
   (%yes) (total n) (89) (4668) (87) (808) (90) (3860)
Alcohol
   ≥7 units/week, yes/no 1515/3127 275/530 1240/2597
0.33
   (%yes) (total n) (33) (4642) (34) (805) (32) (3837)
Central Obesity
   Mean ± SD (n) 0.88 ± 0.23 0.91 ± 0.24 0.87 ± 0.23 0.0003
   Q1 (n/total, %) 1059/4235 (25.0) 154/719 (21.4) 905/3516 (25.7)
0.005
   Q2 (n/total, %) 1059/4235 (25.0) 167/719 (23.2) 892/3516 (25.4)
   Q3 (n/total, %) 1059/4235 (25.0) 186/719 (25.9) 873/3516 (24.8)
   Q4 (n/total, %) 1058/4235 (25.0) 212/719 (29.5) 846/3516 (24.1)
Table 1. Baseline characteristics for the studied women. *Women with no history of cancer. **Women with a 
cancer diagnosis vs. non-cases. t-test for continuous data and chi-squared test for categorical data.
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quartile (Table 3). A test for trend over the quartiles was significant for BMI and non-significant for central obe-
sity (p for trend; BMI: p = 0.006, central obesity: p = 0.12).
For both GI and FGO cancers the analyses showed a significantly increased risk of cancer when comparing 
the first and third quartile of central obesity (GI: [HR: 1.56, CI: 0.04]; FGO: [HR: 1.93, CI: 1.01-3.70]). Only for 
FGO cancers, the same association was observed when comparing the fourth quartile of central obesity with the 
first quartile (HR: 1.95, CI: 1.00-3.78).
In contrast, BMI was non-significant in both analyses (Table 3). Trend analyses showed that increased central obe-
sity was positively associated with risk of GI and FGO cancers (p for trend: GI: p = 0.033, FGO: p = 0.039). There was 
no significant trend between increased BMI and risk of GI and FGO cancers (p for trend: GI: p = 0.91, FGO: p = 0.28).
For breast cancer, central obesity was not significantly associated with cancer risk, but here the fourth quartile of 
BMI was significantly associated with increased breast cancer risk when compared to the first quartile (HR: 1.63, CI: 
1.00-2.64). In a test for trend, BMI was also significant in the analysis of breast cancer (p for trend = 0.01).
Neither BMI or central obesity was associated with an increased risk of other cancers (Table 3).
Central obesity and smoking habits. To determine whether central obesity was independently associ-
ated with cancer risk regardless of smoking habits, the women were stratified into three groups; never smokers 
(n = 2,229), former smokers (n = 1,403) and current smokers (n = 1,063). The prevalence of a solid cancer diag-
nosis at least 6 months after baseline within the three groups was distributed in the following way; never smokers: 
18% (n = 333), former smokers: 24% (n = 272) and current smokers: 24% (n = 204).
A multivariable Cox regression analysis adjusted for covariates revealed that the fourth quartile of central 
obesity was significantly associated with increased risk for overall cancer diagnosis in current smokers when com-
pared to the first quartile of central obesity (HR: 1.93, CI: 1.25-2.99). In former smokers, the second, third and 
fourth quartiles of central obesity were all significantly associated with increased overall cancer risk (Q1vs.Q2: 
[HR: 1.79, CI: 1.16-2.75], Q1vs.Q3: [HR: 1.89, CI: 1.23-2.93], Q1vs.Q4: [HR: 1.90, CI: 1.23-2.94]) (Table 4). A test 
Factors
Univariable analysis
Multivariable regression 
analysis
n, casesHR (95% CI) P-value HR (95% CI) P-value
BMI
   Q1 (ref) — (ref) — 1067, 181
   Q2 0.95 (0.77–1.17) 0.63 0.90 (0.73–1.12) 0.34 1062, 176
   Q3 0.99 (0.81–1.22) 0.95 0.91 (0.73–1.14) 0.42 1043, 179
   Q4 0.97 (0.79–1.20) 0.81 0.88 (0.70–1.10) 0.26 1029, 177
Recreational walking
   (<5 times/week) (ref) — (ref) — 1153, 210
   (≥5 times/week) 0.87 (0.74–1.02) 0.09 0.89 (0.76–1.05) 0.18 3048, 503
Exercise habits
   (<1 time/week) (ref) — (ref) — 1268, 229
   (≥1 time/week) 0.89 (0.76–1.04) 0.15 0.93 (0.79–1.10) 0.40 2449, 484
Education
   School (9 years) (ref) — (ref) — 3007, 517
   High school (12 years) 0.95 (0.79–1.14) 0.57 0.94 (0.78–1.13) 0.51 899, 143
   University (17 years) 1.01 (0.76–1.34) 0.97 0.96 (0.72–1.28) 0.77 295, 53
Smoking
   Never (ref) — 1994, 294
   Former 1.34 (1.13–1.59) <0.001 1.29 (1.09–1.53) 0.003 1270, 246
   Current 1.45 (1.20–1.76) <0.001 1.39 (1.15–1.69) <0.001 937, 173
Childbirth
   (<1 child) (ref) — (ref) — 448, 88
   (≥1 child) 0.87 (0.70–1.10) 0.25 0.87 (0.70–1.10) 0.24 3128, 625
Alcohol
   (<7 units/week) (ref) — (ref) — 2815, 470
   (≥7 units/week) 1.09 (0.93–1.28) 0.27 1.05 (0.89–1.23) 0.56 1386, 243
Central Obesity
   Q1 (ref) — (ref) — 1053, 151
   Q2 1.10 (0.88–1.37) 0.40 1.14 (0.90–1.43) 0.27 1049, 167
   Q3 1.21 (0.97–1.50) 0.09 1.26 (1.00–1.58) 0.05 1048, 183
   Q4 1.45 (1.17–1.79) <0.001 1.50 (1.20–1.88) <0.001 1051, 212
Table 2. Univariable and multiple Cox regression analyzing women diagnosed with cancer vs. non-cases*. 
*Women with no history of cancer. Univariable and multivariable adjusted analysis was conducted on the 
complete dataset: n = 4201, cases = 713. Abbreviations: BMI, Body Mass Index.
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for trend over the quartiles of central obesity was significant both in the group of former and current smokers. In 
former smokers, the second quartile of BMI was significantly associated with increased overall cancer risk when 
compared to the first quartile of BMI. In never smokers, neither BMI or central obesity were significantly associ-
ated with overall cancer risk. When stratifying for both smoking habits and site-specific cancer the sample-size 
became too small for a meaningful analysis.
Discussion
In this prospective study including 4,679 postmenopausal women, we found that (i) high central obesity was 
independently associated with increased risk of overall cancers, (ii) high central obese women had significantly 
increased risk of respiratory, GI and FGO cancer when compared to low central women and (iii) when stratifying 
the analysis by smoking habits, high central obesity was significantly associated with cancer risk in former and 
current smokers.
Factors
Respiratory 
Cancers GI Cancers Breast Cancer FGO Cancers Other Cancers
HR (95% CI); P-
value; [n, cases]
HR (95% CI); P-
value; [n, cases]
HR (95% CI); P-
value; [n, cases]
HR (95% CI); P-
value; [n, cases]
HR (95% CI); P-
value; [n, cases]
BMI
   Q1 (ref); [44,930] (ref); [47,933] (ref); [33,919] (ref); [22,909] (ref); [35,921]
   Q2 0.52 (0.30–0.88); 0.02; [908, 22]
0.88 (0.58–1.34); 0.55; 
[933, 47]
0.98 (0.60–1.61); 0.93; 
[920, 34]
0.82 (0.45–1.50); 
0.53; [910, 24]
1.24 (0.79–1.95); 0.35; 
[935, 49]
   Q3 0.54 (0.31–0.93); 0.03; [887, 23]
1.23 (0.82–1.84); 0.31; 
[930, 66]
1.27 (0.78–2.08); 0.33; 
[906, 42]
0.59 (0.31–1.12); 
0.11; [883, 19]
0.73 (0.44–1.24); 0.25; 
[893, 29]
   Q4 0.39 (0.21–0.73); 0.003; [869, 17]
0.77 (0.49–1.22); 0.26; 
[894, 42]
1.63 (1.00–2.64); 0.05; 
[905, 53]
0.83 (0.45–1.53); 
0.55; [882, 30]
0.84 (0.50–1.40); 0.49; 
[887, 35]
Recreational walking
   (<5 times/week) (ref); [36,979] (ref); [59,1002] (ref); [44,987] (ref); [26,969] (ref); [45,988]
   (≥5 times/week) 0.77 (0.51–1.17); 0.22; [2615, 70]
0.92 (0.68–1.26); 0.61; 
[2688, 143]
0.96 (0.68–1.37); 0.82; 
[2663, 118]
1.00 (0.63–1.59); 
1.00; [2614, 69]
0.81 (0.57–1.17); 0.26; 
[2648, 103]
Exercise habits
   (<1 time/week) (ref); [43,1082] (ref); [62,1001] (ref); [41,1080] (ref); [35,1074] (ref); [48,1087]
   (≥1 time/week) 0.74 (0.49–1.10); 0.13; [2512, 63]
1.00 (0.73–1.35); 0.98; 
[2589, 140]
1.27 (0.88–1.82); 0.20; 
[2570, 121]
0.68 (0.44–1.04); 
0.08; [2509, 60]
0.88 (0.62–1.26); 0.49; 
[2549, 100]
Education
   School (9 yrs) (ref); [80,2570] (ref); [141,2631] (ref); [116,2606] (ref); [74,2564] (ref) [106,2596]
   High school (12 yrs) 0.91 (0.56–1.49); 0.72; [777, 21]
1.02 (0.72–1.44); 0.92; 
[798, 42]
1.04 (0.71–1.52); 0.84; 
[792, 36]
0.68 (0.39–1.19); 
0.18; [771, 15]
0.90 (0.59–1.36, 0.61) 
[785, 29]
   University (17 yrs) 0.65 (0.26–1.62); 0.35; [247, 5]
1.24 (0.76–2.03); 0.38; 
[261, 19]
0.84 (0.44–1.61); 0.60; 
[252, 10]
0.78 (0.34–1.82); 
0.57; [248, 6]
1.10 (0.61–1.97, 0.76) 
[255, 13]
Smoking
   Never (ref); [9,1709] (ref); [83,1783] (ref); [78,1778] (ref); [51,1751] (ref); [73,1777]
   Former 6.30 (2.90–13.66); <0.0001; [1057, 33]
1.41 (1.03–1.93); 0.03; 
[1099, 75]
1.07 (0.75–1.52); 0.72; 
[1077, 53]
1.04 (0.67–1.61); 
0.86; [1058, 34]
1.13 (0.79–1.62); 0.51; 
[1075, 51]
   Current 15.28 (7.26–32.13; <0.0001; [828, 64]
1.37 (0.94–1.99); 0.10; 
[808, 44]
1.03 (0.67–1.58); 0.89; 
[795, 31]
0.45 (0.23–0.89); 
0.02; [774, 10]
0.79 (0.50–1.27); 0.33; 
[788, 24]
Childbirth
   (<1 child) (ref); [13,373] (ref); [24,384] (ref); [18,378] (ref); [10,370] (ref); [23,383]
   (≥1 child) 0.86 (0.48–1.55); 0.62; [3221, 93]
0.91 (0.59–1.41); 0.68; 
[3306, 178]
0.91 (0.56–1.50); 0.72; 
[3272, 144]
0.96 (0.50–1.86); 
0.90; [3213, 85]
0.67 (0.42–1.05); 0.08; 
[3253, 125]
Alcohol
   (<7 units/week) (ref); [67,2412] (ref); [133,2478] (ref); [101,2446] (ref); [67,2412] (ref); [102,2447]
   (≥7 units/week) 1.03 (0.69–1.54); 0.89; [1182, 39]
1.04 (0.77–1.41); 0.78; 
[1212, 69]
1.33 (0.96–1.84); 0.09; 
[1204, 61]
0.92 (0.58–1.44); 
0.70; [1171, 28]
0.92 (0.65–1.32); 0.65; 
[1189, 46]
Central Obesity
   Q1 (ref); [28,930] (ref); [38,940] (ref); [35,937] (ref); [16,918] (ref); [34,936]
   Q2 1.02 (0.57–1.85); 0.94; [902, 20]
1.36 (0.88–2.11); 0.16; 
[933, 51]
1.04 (0.64–1.66); 0.89; 
[922, 40]
1.24 (0.63–2.45); 
0.54; [902, 20]
1.08 (0.66–1.76); 0.76; 
[918, 36]
   Q3 1.07 (0.58–1.97); 0.82; [886, 21]
1.56 (1.01–2.41); 0.04; 
[923, 58]
0.96 (0.59-1.57); 0.88; 
[903, 38]
1.93 (1.01–3.70); 
0.05; [895, 30]
1.16 (0.71–1.91); 0.55; 
[901, 36]
   Q4 2.01 (1.17–3.47), 0.01; [876, 37]
1.55 (0.99–2.41); 0.05; 
[894, 55]
1.26 (0.79–2.03); 0.33; 
[888, 49]
1.95 (1.00–3.78); 
0.05; [868, 29]
1.41 (0.87–2.31); 0.17; 
[881, 42]
Table 3. Multivariable Cox regression analysis*: Women diagnosed with different cancers types vs. non-
cases**. *Analysis was conducted on complete datasets: Respiratory cancers, n = 3594, cases = 106, GI cancers, 
n = 3690, cases = 202, Breast cancer, n = 3650, cases = 162, FGO cancers, n = 3583, cases = 95, Other cancer, 
n = 3636, cases = 148. **Women with no history of cancer. Abbreviations: GI, Gastrointestinal; FGO, Female 
Genital Organs; BMI, Body Mass Index.
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These findings extend our understanding of the link between obesity and cancer and provide strong sup-
port for a positive association between central obesity and risk of some cancers in postmenopausal women. 
Furthermore, our findings underline the importance of including measures of body fat distribution in risk anal-
yses, as obesity derived from BMI and body fat distribution describe two different obesity-types that have a 
different impact on risk.
Several studies have investigated the relationship between different cancer subtypes and anthropometric 
measures of obesity5,20. In alignment with our results, Wang et al. found a significant association between WC and 
increased risk of colorectal cancer in a cohort of 87,261 women21. For lung cancer, previous studies have shown 
an increased BMI to be a protective factor22. Reeves et al. found a 34% decreased risk of lung cancer for every 10 
unit increase in BMI in a cohort of 1.2 million elderly women23. These results are consistent with our results which 
showed that an elevated BMI was inversely associated with respiratory cancer risk. In contrast, we found a signif-
icant positive association between high central obesity and respiratory cancers after adjusting for BMI and other 
cofounders. This suggests that while a high BMI is protective for respiratory cancer, high central obesity might be 
a risk factor. These results substantiate a recent meta-analysis, which concluded that central obesity, measured by 
WC and WHR, may play a role in the development of lung cancer24.
The biological mechanism behind the contradictory association between central obesity and general obesity 
to lung cancer remains poorly understood. Possible explanations could involve hyperinsulinemia and increased 
unbound estrogens, both of which have a stronger correlation to central obesity compared to general obesity24,25. 
Other studies have also suggested that reduced oxidative DNA damage, which is inversely correlated to BMI, 
could explain the protective effect of a high BMI in lung cancer26,27. Nonetheless, further research is warranted to 
understand the associations between central obesity and general obesity to lung cancer.
The link between obesity and hormone-associated cancers, such as breast, endometrial and ovarian cancer, 
is well established in postmenopausal women and thought to be mediated by increased concentrations of circu-
lating sex hormones23,28. In the Million Women Study, a 10 unit increase in BMI was associated with a four times 
higher likelihood for developing endometrial cancer23, which is in line with our results where central obesity is 
significantly associated with FGO cancer. Furthermore, in a study of 10,960 elderly women, Rohan et al. showed 
a strong positive association between both BMI and ratio of trunk fat mass to average of legs fat mass and breast 
cancer28. In this study, we also found a significant association between BMI and breast cancer, but central obe-
sity did not show any significant association to breast cancer risk, though a similar trend for central obesity was 
Factors
Never smokers Former smokers Current smokers
HR (95% CI); P-value; [n, cases] HR (95% CI); P-value; [n, cases] HR (95% CI); P-value; [n, cases]
BMI
    Q1 (ref) [58,438] (ref) [59,289] (ref) [64,340]
    Q2 1.15 (0.81–1.63); 0.43; [521, 79] 0.66 (0.45–0.97); 0.04; [301, 51] 0.89 (0.60–1.33); 0.58; [240, 46]
    Q3 1.15 (0.80–1.65); 0.45; [508, 78] 0.74 (0.50–1.09); 0.13; [326, 61] 0.86 (0.57–1.31); 0.49; [209, 40]
    Q4 1.11 (0.77–1.61); 0.57; [527, 79] 0.80 (0.55–1.16); 0.24; [354, 75] 0.61 (0.36–1.01); 0.05; [148, 23]
Recreational walking
   (<5 times/week) (ref) [91,517] (ref) [66,357] (ref) [53,279]
    (≥5 times/week) 0.75 (0.58–0.96); 0.02; [1477, 203] 1.07 (0.81–1.43); 0.63; [913, 180] 0.96 (0.69–1.33); 0.79; [658, 120]
Exercise habits (ref)
   (<1 time/week) (ref) [83,541] (ref) [74,359] (ref) [72,368]
    (≥1 time/week) 1.05 (0.81–1.36); 0.72; [1453, 211] 0.91 (0.69–1.20); 0.49; [911, 172] 0.85 (0.62–1.15); 0.29; [569, 101]
Education
    School (9 years) (ref) [207,1409] (ref) [177,892] (ref) [133,706]
    High school (12 years) 1.00 (0.75–1.33); 1.00; [439, 62] 0.93 (0.68–1.28); 0.66; [274, 52] 0.83 (0.55–1.25); 0.37; [186, 29]
    University (17 years) 1.10 (0.72–1.68); 0.66; [146, 25] 0.75 (0.45–1.24); 0.26; [104, 17] 1.11 (0.59–2.08); 0.75; [45, 11]
Childbirth
    (<1 child) (ref) [30,191] (ref) [31,147] (ref) [27,110]
    (≥1 child) 0.98 (0.67–1.43); 0.91; [1803, 264] 0.89 (0.61–1.30); 0.55 [1123, 215] 0.74 (0.49–1.12); 0.15; [827, 146]
Alcohol
   (≥7 units/week) (ref) [209,1426] (ref) [149,785] (ref) [112,604]
(≥7 units/week) 1.04 (0.80–1.34); 0.79; [568, 85] 1.10 (0.85–1.43); 0.47 [485, 97] 0.97 (0.71–1.34); 0.86; [333, 61]
Central obesity
    Q1 (ref) [75,508] (ref) [35,272] (ref) [41,273]
    Q2 0.79 (0.56–1.12); 0.19; [533, 66] 1.79 (1.16–2.75); 0.008; [309, 64] 1.25 (0.79–1.98); 0.34; [207, 37]
    Q3 0.91 (0.65–1.28); 0.60; [508, 74] 1.89 (1.23–2.93); 0.004; [324, 70] 1.38 (0.87–2.19); 0.17; [216, 39]
    Q4 1.16 (0.82–1.63); 0.40; [445, 79] 1.90 (1.23–2.94); 0.004; [365, 77] 1.93 (1.25–2.99); 0.003; [241, 56]
Table 4. Multivariable Cox regression analysis*. Women diagnosed with cancer vs. non-cases** stratified 
by smoking status. *Analysis was conducted on the complete datasets: Never smokers, n = 1994, cases = 294; 
Former smoker, n = 1270, cases = 246; Current smokers, n = 937, cases = 173. **Women with no history of 
cancer. Abbreviations: BMI, Body Mass Index.
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observed. An explanation for the conflicting results might be the lower power in this study or that we in this 
study include both BMI and central obesity in the analysis whereas Rohan et al. perform separate analyses for the 
obesity measures.
Postmenopausal women tend to experience a re-distribution of body fat from a gynoid to an android pattern 
which has been linked to the metabolic syndrome and increased risk of cardiovascular diseases28. In line with 
this, we have previously seen, in a PERF subpopulation, that localization of fat mass was more important for 
atherosclerosis than general obesity29. Level of physical activity may also influence the accumulation of fat. In a 
recent study including 10,976 individuals from the general population30, cardiorespiratory fitness was found to be 
inversely associated with both central obesity and low-grade inflammation independent of BMI. Moreover, phys-
ical inactivity is an independent cause of the accumulation of visceral fat31 and regular exercise decreases central 
obesity and exerts anti-inflammatory effects32. Thus, high central obesity may reflect low fitness and low-grade 
inflammation, which are both associated with an increased risk of cancer33.
Smoking is also known to affect the body fat distribution resulting in smokers having a higher waist cir-
cumference compared to non-smoker34,35. Furthermore, an association between lung cancer and BMI in former 
smokers has previously been shown36, though others have provided evidence that obesity may act as a protective 
factor against lung cancer37. In this study we found that high central obesity was significantly associated with 
increased risk of overall cancer in former and current smokers, but not in never smokers. We also found that the 
second quartile of BMI was inversely associated with overall cancer risk in former smokers. This substantiates the 
claim of stratification by smoking habits when assessing obesity and cancer risk13, and suggests that in former and 
current smokers general and central obesity reflect different risk.
As a whole, the results of this paper support the growing evidence that the distribution of body fat after men-
opause is as important as the fat mass itself when studying the risk of obesity-related diseases28. This article adds 
to the knowledge about age-related diseases and postmenopausal obesity. Understanding the complex biology 
underlying the association between central obesity and menopause could, therefore, serve, not only as prevention 
strategies for cardiovascular diseases but also as cancer prevention strategies.
Limitations of this study include the number of cancer diagnoses, which was low when both sub-dividing for 
site-specific cancer and stratifying by smoking habits. Due to the small sample size, it was also impossible to sub-
divide the cancer-types even further by individual cancer sites. The data is restricted to postmenopausal Danish 
Caucasian women and may therefore not be generalizable to the general world population. The choice of variables 
to include in the analyses was restricted to the data present in the PERF study. The often-used measures WHR 
and WC were not recorded at baseline, why it was impossible to compare these measures with the central obesity 
measure from the DXA-scanning. Lastly, the study design does not allow an assessment of the causal role of cen-
tral obesity in relation to cancer risk. The strength of this study includes the prospective design, the long follow up 
period and the access to the Danish health registries. Furthermore, the PERF cohort represents a limited number 
of cohorts where postmenopausal women are evaluated with DXA-scans38.
In conclusion, our study supports several relevant hypotheses. Firstly, we show that central obesity is inde-
pendently associated with an increased risk of overall cancers. Secondly, we show that women with high central 
obesity have more than 50% increased risk of respiratory, GI and FGO cancers respectively compared to women 
with low central obesity. Lastly when stratifying the analysis by smoking habits high central obesity was signif-
icantly associated with cancer risk in former and current smokers. These results suggest that central obesity is 
at least partially independent of BMI and that different types of obesity have a diverse impact on health. This 
underlines that health strategies on keeping a healthy weight should be supplemented by recommendation on 
preventing central obesity, especially for women facing the menopause transition.
Data Availability
The original data of the Prospective Epidemiological Risk Factor study and the linkage data from various health 
registries are currently stored in Nordic Bioscience. Access to this database will be granted, on condition that 
researchers have appropriate ethical permission and sign the appropriate Material Transfer Agreement form.
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